BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.100
0.00 (0.00%)
Oct 23, 2026, 1:44 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 32.86 million as of October 23, 2026. It is the 41,152nd most valuable company in the world and the 438th biggest in Israel. Its market cap has decreased by 40.07% in one year.
Market Cap
32.86M
Enterprise Value
26.04M
Revenue
4.15M
Global Rank
Country Rank
#438 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 32.86M, an increase of 20,054.10%. That is a compound annual growth rate of 30.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 32.86M | -21.35% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 210.26M |
| Matricelf | 82.17M |
| Clal Biotechnology Industries | 34.04M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.24M |
| XTL Biopharmaceuticals | 19.87M |
| Evogene | 18.55M |
| Can-Fite BioPharma | 18.49M |